First Time Loading...

Edesa Biotech Inc
NASDAQ:EDSA

Watchlist Manager
Edesa Biotech Inc Logo
Edesa Biotech Inc
NASDAQ:EDSA
Watchlist
Price: 4.6325 USD 1.7% Market Closed
Updated: May 4, 2024

Edesa Biotech Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Edesa Biotech Inc
Net Income (Common) Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Edesa Biotech Inc
NASDAQ:EDSA
Net Income (Common)
-$7.7m
CAGR 3-Years
1%
CAGR 5-Years
-9%
CAGR 10-Years
9%
Zymeworks Inc
NYSE:ZYME
Net Income (Common)
-$118.7m
CAGR 3-Years
13%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Net Income (Common)
-$93.8m
CAGR 3-Years
-21%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Net Income (Common)
-$94.9m
CAGR 3-Years
-6%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Net Income (Common)
-$78m
CAGR 3-Years
9%
CAGR 5-Years
-4%
CAGR 10-Years
-40%
Spectral Medical Inc
TSX:EDT
Net Income (Common)
-CA$15.7m
CAGR 3-Years
-20%
CAGR 5-Years
-44%
CAGR 10-Years
-3%

See Also

What is Edesa Biotech Inc's Net Income (Common)?
Net Income (Common)
-7.7m USD

Based on the financial report for Dec 31, 2023, Edesa Biotech Inc's Net Income (Common) amounts to -7.7m USD.

What is Edesa Biotech Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
9%

Over the last year, the Net Income (Common) growth was 50%. The average annual Net Income (Common) growth rates for Edesa Biotech Inc have been 1% over the past three years , -9% over the past five years , and 9% over the past ten years .